HD-OPM Archive
Topics › LDL, ApoB & lipid panel

National Lipid Association consensus clarifies when to test apoB

Louis Nervegna · Apr 02, 2026 · ♥ 4 reactions · 13 comments · original Facebook post
LDL, ApoB & lipid panelGuidelines, policy & public health
↻ This is a repost. The main version (highest ranked) is NLA consensus: apoB testing helps when LDL-C and risk are discordant · Oct 15, 2024.
AI summary & key facts

A shared summary of the NLA expert consensus: apoB, on all atherogenic lipoproteins, can predict risk better than LDL-C, especially when the two diverge after statins. Testing is most useful for borderline-risk patients deciding on a statin or those considering intensification.

#guidelinesHD #apobHD #ldlHD #ldlcHD

Research cited

Shared from Gokhan Can · original post

ApoB Testing in Lipid Management: New Guidelines Clarify Role and Importance

The article discusses new guidelines for apolipoprotein B (apoB) testing in lipid management, as outlined by the National Lipid Association's Expert Clinical Consensus. ApoB is a protein found on all atherogenic lipoproteins and is considered a more accurate predictor of cardiovascular risk than LDL cholesterol (LDL-C) alone. While apoB and LDL-C levels often correlate, they can diverge in some individuals, particularly after statin treatment. In such cases, apoB remains a better indicator of cardiovascular outcomes, potentially leading to more accurate risk assessment and treatment decisions.

The consensus statement suggests that apoB testing may be particularly useful in two scenarios: for patients with borderline cardiovascular disease risk who are deciding whether to start statin therapy, and for those already on statins who are considering treatment intensification. The guidelines provide specific apoB treatment thresholds that correspond to established LDL-C goals. However, the statement emphasizes that routine apoB measurement is not necessary for all patients and remains a matter of clinical judgment. It may be most beneficial for individuals with conditions such as hypertriglyceridemia, diabetes, visceral adiposity, insulin resistance, metabolic syndrome, low HDL-C, or very low LDL-C levels.

MedscapeHeard of ApoB Testing? New GuidelinesDr Neil Skolnik highlights the key points for primary care clinicians from a new consensus statement on apolipoprotein B testing.medscape.comNo photo description available.
← newer: Blood cholesterol levels have no bearing on brain cholesteroolder: Analysis of 125 million statin users links statins to lower →